Vladimir Kolesnichenko PhD

Vladimir Kolesnichenko PhD

Professor
  • Synthesis and     characterization of ultrasmall magnetic nanoparticles for biomedical     applications.
  • we are developing novel MRI imaging agents which be     selectively recognized by cancerous cells.  Their size and     amphiphilic properties will be optimized to avoid phagocytic and     early renal clearance, which will make them an effective tool for early     detection of cancer.  
  • National Taras Shevchenko University, Kyiv, Ukraine     (BS, MS); Institute of General and Inorganic Chemistry, Kyiv,     Ukraine (PhD); The University of Iowa (Postdoc)
  • ORCID: https://orcid.org/0000-0001-5497-7085
  • NCBI: https://www.ncbi.nlm.nih.gov/sites/myncbi/1hEVrJkxduZ5J/bibliography/48720938/public/?page=1
  • Selected publications: (a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces.  Rajesh Komati, Carl     Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir     Kolesnichenko, Chemistry-A European Journal, 2018, 24, 14824-14829.      (b) A Versatile Method of Ambient-Temperature Solvent Removal. Igor     Kolesnichenko, Galina Goloverda and Vladimir Kolesnichenko, Organic     Process Research & Development, 2020, 24, 25-31.
  • Keywords: superparamagnetic nanoparticles, MRI contrast agents

LCRC Faculty

Weishan Huang, PhD
Translational Oncology
LSU - School of Veterinary Medicine
Thomas Huckaba PhD
Drug Discovery
Xavier University
Reza Izadpanah, DVM PhD
Cancer Biology
Tulane University School of Medicine
James Jackson PhD
Cancer Biology
Tulane University School of Medicine
Amelia Jernigan MD
Translational Oncology
LSU Health - New Orleans
Jun-yuan Ji PhD
Cancer Biology
Tulane University School of Medicine
Xiang Ji PhD
Population Sciences
Tulane University School of Medicine
Seetharama D Jois PhD
Translational Oncology
University of Louisiana Monroe
Lindsey Keith-Vincent EdD
Cancer Biology
Louisiana Tech University